• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LKB1 失活通过 p53 依赖性上调 survivin 导致着丝粒缺陷和基因组不稳定性。

LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin.

机构信息

State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.

Department of General Surgery, The Second Affiliated Hospital, Soochow University, Suzhou 215004, China.

出版信息

Aging (Albany NY). 2020 Jul 16;12(14):14341-14354. doi: 10.18632/aging.103473.

DOI:10.18632/aging.103473
PMID:32668413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7425461/
Abstract

Inactivating mutations in the liver kinase B1 (LKB1) tumor suppressor gene underlie Peutz-Jeghers syndrome (PJS) and occur frequently in various human cancers. We previously showed that LKB1 regulates centrosome duplication via PLK1. Here, we report that LKB1 further helps to maintain genomic stability through negative regulation of survivin, a member of the chromosomal passenger complex (CPC) that mediates CPC targeting to the centromere. We found that loss of LKB1 led to accumulation of misaligned and lagging chromosomes at metaphase and anaphase and increased the appearance of multi- and micro-nucleated cells. Ectopic LKB1 expression reduced these features and improved mitotic fidelity in LKB1-deficient cells. Through pharmacological and genetic manipulations, we showed that LKB1-mediated repression of survivin is independent of AMPK, but requires p53. Consistent with the key influence of LKB1 on survivin expression, immunohistochemical analysis indicated that survivin is highly expressed in intestinal polyps from a PJS patient. Lastly, we reaffirm a potential therapeutic avenue to treat LKB1-mutated tumors by demonstrating the increased sensitivity to survivin inhibitors of LKB1-deficient cells.

摘要

肝激酶 B1(LKB1)肿瘤抑制基因的失活突变是 Peutz-Jeghers 综合征(PJS)的基础,并且经常发生在各种人类癌症中。我们之前表明,LKB1 通过 PLK1 调节中心体复制。在这里,我们报告 LKB1 通过负调控染色体乘客复合物(CPC)的成员 survivin 进一步有助于维持基因组稳定性,该复合物介导 CPC 向着丝粒的靶向。我们发现 LKB1 的缺失导致中期和后期染色体的错位和滞后积累,并增加多核和微核细胞的出现。异位 LKB1 表达减少了这些特征,并改善了 LKB1 缺陷细胞的有丝分裂保真度。通过药理学和遗传操作,我们表明 LKB1 介导的 survivin 抑制不依赖于 AMPK,但需要 p53。与 LKB1 对 survivin 表达的关键影响一致,免疫组织化学分析表明 PJS 患者的肠息肉中高表达 survivin。最后,我们通过证明 LKB1 缺陷细胞对 survivin 抑制剂的敏感性增加,再次证实了治疗 LKB1 突变肿瘤的潜在治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/a21baf095e6b/aging-12-103473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/9bb43ca6e842/aging-12-103473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/b379678333c1/aging-12-103473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/2acb2617ba60/aging-12-103473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/2d3eed6d4745/aging-12-103473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/91a72e265835/aging-12-103473-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/adf6a56b4396/aging-12-103473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/87991c1d4ed6/aging-12-103473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/a21baf095e6b/aging-12-103473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/9bb43ca6e842/aging-12-103473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/b379678333c1/aging-12-103473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/2acb2617ba60/aging-12-103473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/2d3eed6d4745/aging-12-103473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/91a72e265835/aging-12-103473-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/adf6a56b4396/aging-12-103473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/87991c1d4ed6/aging-12-103473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/7425461/a21baf095e6b/aging-12-103473-g008.jpg

相似文献

1
LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin.LKB1 失活通过 p53 依赖性上调 survivin 导致着丝粒缺陷和基因组不稳定性。
Aging (Albany NY). 2020 Jul 16;12(14):14341-14354. doi: 10.18632/aging.103473.
2
A novel de novo mutation in LKB1 gene in a Chinese Peutz Jeghers syndrome patient significantly diminished p53 activity.一个新的 LKB1 基因突变导致中国一位 Peutz-Jeghers 综合征患者的 p53 活性显著降低。
Clin Res Hepatol Gastroenterol. 2011 Mar;35(3):221-6. doi: 10.1016/j.clinre.2010.11.008. Epub 2011 Mar 15.
3
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.Lkb1肿瘤抑制因子的缺失会引发肠道息肉病,但对肿瘤转化具有抗性。
Nature. 2002 Sep 12;419(6903):162-7. doi: 10.1038/nature01045.
4
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.黑斑息肉综合征基因产物LKB1是p53依赖性细胞死亡的介质。
Mol Cell. 2001 Jun;7(6):1307-19. doi: 10.1016/s1097-2765(01)00258-1.
5
Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome.黑斑息肉综合征患者胃肠道息肉中LKB1和β-连环蛋白基因的体细胞突变
Cancer Res. 2000 Nov 15;60(22):6311-3.
6
Mutation analysis of related genes in hamartoma polyp tissue of Peutz-Jeghers syndrome.Peutz-Jeghers 综合征错构瘤息肉组织相关基因的突变分析。
World J Gastroenterol. 2020 Apr 28;26(16):1926-1937. doi: 10.3748/wjg.v26.i16.1926.
7
Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome.黑斑息肉综合征患者错构瘤性息肉和癌中的分子遗传学改变。
J Clin Pathol. 2001 Feb;54(2):126-31. doi: 10.1136/jcp.54.2.126.
8
Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity.黑斑息肉综合征中LKB1激酶活性的丧失,以及等位基因和基因座异质性的证据。
Am J Hum Genet. 1998 Dec;63(6):1641-50. doi: 10.1086/302159.
9
LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.LKB1 突变在黏液性细支气管肺泡癌中经常被检测到。
Jpn J Clin Oncol. 2011 Sep;41(9):1132-7. doi: 10.1093/jjco/hyr102. Epub 2011 Aug 4.
10
Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.黑斑息肉综合征激酶LKB1的稳定性需要其与分子伴侣Hsp90/Cdc37结合。
Oncogene. 2003 Dec 11;22(57):9165-75. doi: 10.1038/sj.onc.1207179.

引用本文的文献

1
Loss of Lkb1 cooperates with Braf and ultraviolet radiation, increasing melanoma multiplicity and neural-like dedifferentiation.Lkb1缺失与Braf及紫外线辐射协同作用,增加黑色素瘤的多发性及神经样去分化。
Mol Oncol. 2025 Feb;19(2):329-343. doi: 10.1002/1878-0261.13715. Epub 2024 Aug 8.
2
Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma.外泌体中的肝激酶 B1 抑制免疫检查点程序性死亡配体 1 和肝内胆管癌的转移进展。
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8367. Epub 2022 Jul 20.
3
LKB1: Can We Target an Hidden Target? Focus on NSCLC.

本文引用的文献

1
Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer.LKB1 蛋白表达缺失与 II 期或 III 期结肠癌患者术后复发和死亡风险增加相关。
Cancer Res Treat. 2019 Oct;51(4):1518-1526. doi: 10.4143/crt.2019.008. Epub 2019 Mar 20.
2
Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer.肝激酶B1对胃癌中p53和生存素的影响及其与预后的相关性
Onco Targets Ther. 2019 Feb 22;12:1439-1445. doi: 10.2147/OTT.S199138. eCollection 2019.
3
Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia.
LKB1:我们能否靶向一个隐藏的靶点?聚焦于非小细胞肺癌。
Front Oncol. 2022 May 11;12:889826. doi: 10.3389/fonc.2022.889826. eCollection 2022.
使用YM155(溴化司帕沙星)靶向生存素:一种治疗儿童急性髓系白血病的新策略。
Leuk Res. 2015 Apr;39(4):435-44. doi: 10.1016/j.leukres.2015.01.005. Epub 2015 Jan 23.
4
Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.组蛋白去乙酰化酶2的选择性抑制通过MDM2蛋白酶体降解诱导p53依赖的生存素下调。
Oncotarget. 2015 Sep 22;6(28):26528-40. doi: 10.18632/oncotarget.3100.
5
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation.一种小鼠模型揭示LKB1作为紫外线B诱导的DNA损伤传感器,介导细胞周期蛋白依赖性激酶抑制因子1A(p21WAF1/CIP1)的降解。
PLoS Genet. 2014 Oct 16;10(10):e1004721. doi: 10.1371/journal.pgen.1004721. eCollection 2014 Oct.
6
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.LKB1 在高级别子宫内膜癌中的缺失:LKB1 是 p53 的一个新的转录靶标。
Cancer. 2014 Nov 15;120(22):3457-68. doi: 10.1002/cncr.28854. Epub 2014 Jul 16.
7
Liver kinase B1 regulates the centrosome via PLK1.肝脏激酶B1通过PLK1调节中心体。
Cell Death Dis. 2014 Apr 10;5(4):e1157. doi: 10.1038/cddis.2014.135.
8
Survivin and YM155: how faithful is the liaison?生存素与YM155:二者联系有多紧密?
Biochim Biophys Acta. 2014 Apr;1845(2):202-20. doi: 10.1016/j.bbcan.2014.01.003. Epub 2014 Jan 16.
9
Three wise centromere functions: see no error, hear no break, speak no delay.着丝粒的三个明智功能:不见错误、不闻断裂、不说延迟。
EMBO Rep. 2013 Dec;14(12):1073-83. doi: 10.1038/embor.2013.181. Epub 2013 Nov 15.
10
Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.Lkb1/Stk11 通过调控 mTOR 信号转导控制着软骨细胞命运的转变并抑制骨骼肿瘤的形成。
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19450-5. doi: 10.1073/pnas.1309001110. Epub 2013 Nov 11.